Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy H J Goodship

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Trends in Molecular Medicine|May 4, 2004
Mutations in CD46, a complement regulatory protein, predispose to atypical HUSTimothy H J Goodship, M Kathryn Liszewski, Elizabeth J Kemp, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 27, 2007
Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool?Falak Gurreebun, George H Hartley, Alison L Brown, et al.
Blood Purification|December 24, 2005
Telomere shortening and haemodialysisMark C Boxall, Timothy H J Goodship, Alison L Brown, et al.
Biochemical and Biophysical Research Communications|December 31, 2002
Disordered calcium crystal handling in antisense CLC-5-treated collecting duct cellsJohn A Sayer, Georgina Carr, Simon H S Pearce, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomyR Thomas Jagoe, Christopher P F Redfern, Russell G Roberts, et al.
Pediatric Nephrology (Berlin, Germany)|July 24, 2010
Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulationJean-Claude Davin, Charles Majoie, Jaap Groothoff, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic backgroundElena Bresin, Erica Daina, Marina Noris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donorRosemary L Donne, Ian Abbs, Peter Barany, et al.
Molecular Immunology|August 3, 2005
Does complement factor B have a role in the pathogenesis of atypical HUS?David Kavanagh, Elizabeth J Kemp, Anna Richards, et al.
Transplantation|October 13, 2011
Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumabColin H Wilson, Alison L Brown, Steve A White, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Trends in Molecular Medicine|May 4, 2004
Mutations in CD46, a complement regulatory protein, predispose to atypical HUSTimothy H J Goodship, M Kathryn Liszewski, Elizabeth J Kemp, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 27, 2007
Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool?Falak Gurreebun, George H Hartley, Alison L Brown, et al.
Blood Purification|December 24, 2005
Telomere shortening and haemodialysisMark C Boxall, Timothy H J Goodship, Alison L Brown, et al.
Biochemical and Biophysical Research Communications|December 31, 2002
Disordered calcium crystal handling in antisense CLC-5-treated collecting duct cellsJohn A Sayer, Georgina Carr, Simon H S Pearce, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomyR Thomas Jagoe, Christopher P F Redfern, Russell G Roberts, et al.
Pediatric Nephrology (Berlin, Germany)|July 24, 2010
Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulationJean-Claude Davin, Charles Majoie, Jaap Groothoff, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic backgroundElena Bresin, Erica Daina, Marina Noris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donorRosemary L Donne, Ian Abbs, Peter Barany, et al.
Molecular Immunology|August 3, 2005
Does complement factor B have a role in the pathogenesis of atypical HUS?David Kavanagh, Elizabeth J Kemp, Anna Richards, et al.
Transplantation|October 13, 2011
Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumabColin H Wilson, Alison L Brown, Steve A White, et al.
Pageof 8